Keyphrases
Active Ulcerative Colitis
16%
Adalimumab
100%
AIMS™
16%
Albumin
16%
Analysis of Covariance
16%
Bleeding Frequency
50%
Blood Platelet Count
16%
Categorical Variables
16%
Clinical Remission
16%
Clinical Trials
100%
Early Change
16%
Early Improvement
16%
Early Reduction
16%
Early Response
100%
Endoscopy
16%
Health-related Quality of Life
16%
Hematocrit
16%
Hemoglobin
16%
High-sensitivity C-reactive Protein (hs-CRP)
16%
Inflammatory Bowel Disease Questionnaire
16%
Laboratory Markers
16%
Laboratory Parameters
100%
Mantel-Haenszel Test
16%
Mean Reduction
16%
Mucosal Healing
33%
Mucosal Health
16%
Normal mucosa
16%
Placebo
50%
Pooled Analysis
100%
Quality of Life Assessment
33%
Quality of Life Improvement
16%
Rapid Change
100%
Rapid Improvement
16%
Rectal Bleeding
50%
Red Blood Cell Count
16%
Short Form 36 (SF-36)
16%
Stool Frequency
50%
Total Protein
16%
Ulcerative Colitis
100%
Medicine and Dentistry
Adalimumab
100%
Albumin
16%
Analysis of Covariance
16%
C Reactive Protein
16%
Clinical Trial
100%
Endoscopy
16%
Erythrocyte
16%
Hematocrit
16%
Inflammatory Bowel Disease
16%
Mantel Haenszel Test
16%
Mucosa
16%
Patient with Ulcerative Colitis
100%
Placebo
50%
Platelet
16%
Pooled Analysis
100%
Quality of Life
33%
Quality of Life Measure
16%
Rectal Bleeding
50%
Short Form 36
16%
Ulcerative Colitis
16%
Nursing and Health Professions
Adalimumab
100%
Albumin
16%
Analysis of Covariance
16%
C Reactive Protein
16%
Endoscopy
16%
Erythrocyte Count
16%
Hematocrit
16%
Inflammatory Bowel Disease
16%
Mantel Haenszel Test
16%
Patient with Ulcerative Colitis
100%
Placebo
50%
Platelet Count
16%
Quality of Life
33%
Quality of Life Measure
16%
Rectum Hemorrhage
50%
Remission
16%
Short Form 36
16%
Ulcerative Colitis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
100%
Albumin
16%
C Reactive Protein
16%
Clinical Trial
100%
Health Survey
16%
Inflammatory Bowel Disease
16%
Placebo
50%
Rectum Hemorrhage
50%
Remission
16%
Ulcerative Colitis
100%
Veterinary Science and Veterinary Medicine
Hematocrit
50%
Hemocyte
50%
Mucosa
50%
Mucous Membrane
50%
Platelet
50%
Ulcerative Colitis
100%
Immunology and Microbiology
Adalimumab
100%
Albumin
16%
C-Reactive Protein
16%
Erythrocyte Count
16%
Hematocrit
16%
Hemoglobin
16%
Inflammatory Bowel Disease
16%
Mucosa
16%
Platelet Count
16%
Ulcerative Colitis
100%